• 沒有找到結果。

銀杏、人參、五味子萃取物複方對四氯化碳誘發肝 傷害老鼠肝功能的影響

N/A
N/A
Protected

Academic year: 2021

Share "銀杏、人參、五味子萃取物複方對四氯化碳誘發肝 傷害老鼠肝功能的影響"

Copied!
2
0
0

加載中.... (立即查看全文)

全文

(1)

銀杏、人參、五味子萃取物複方對四氯化碳誘發肝 傷害老鼠肝功能的影響

本研究是探討銀杏( Ginkgo biloba )、人參( Panax ginseng )、五 味子( Schizandra chinensis )萃取物複方,對 CCl4 誘發肝傷害老鼠 肝功能,抗氧化力及脂質代謝的影響。 Sprague-Dawley 老鼠以隨機方 式分為正常組、 CCl4 組、 CCl4+sliymarin (200 mg/kg/day) 組、 CCl4 + 一倍劑量( 150 mg/kg/day )組及 CCl4+ 五倍劑量( 750 mg/kg/da y )組,實驗為期六週。結果顯示,第四週時 CCl4 組血漿 GOT 、 G PT 值顯著高於正常組, CCl4+sliymarin 組和 CCl4+ 一倍劑量組之 GO T 有較 CCl4 組顯著下降的情形, CCl4+ 一倍劑量組之 GPT 值也較 C Cl4 組顯著下降。肝臟抗氧化方面, CCl4 組之 SOD 活性顯著低於正 常組,其餘三組與正常組間則無顯著差異,而 CCl4+ 五倍劑量組之 ca talase 活性顯著高於 CCl4 組,肝臟總抗氧化狀態, CCl4 組顯著低於 其他四組, CCl4 組肝臟中脂質過氧化物 MDA 含量顯著高於正常組

, CCl4+ 一倍劑量組及 CCl4+ 五倍劑量組則與正常組間無顯著差異

,病理切片發現, CCl4+ 一倍劑量組及 CCl4+ 五倍劑量組肝纖維化 有較 CCl4 組改善。 CCl4+ 一倍劑量組及 CCl4+ 五倍劑量組血漿總膽 固醇含量顯著低於 CCl4 組。由結果推測,此複方可改善因 CCl4 誘發 肝傷害老鼠之肝臟抗氧化能力,並延緩肝纖維化之發生。

(2)

Effects of Ginkgo biloba, Panax ginseng, and Schizandra chinensis extract on the functions of damaged liver induced by

carbon tetrachlorede

This study investigated the effects of herbal cocktail (Ginkgo biloba, Panax ginseng, and Schi zandra chinensis extract) on hepatic functions, antioxidation and lipid metabolism in rats with CCl4-induced liver damage. Sprague-Dawley rats were randomly divided into control, CCl4, CCl4+silymarin(200 mg/kg), CCl4+1 herbal extract cocktail(HEC; 150 mg/kg), and CCl4+5  HEC(750 mg/kg) groups. The experimental period was 6 weeks. The results showed that the

 CCl4 group significantly increased plasma GOT and GPT activities at week 4 compared with t he control group. However, the 1 HEC group significantly decreased plasma GOT and GPT a  ctivities at week 4 compared with the CCl4 group. Hepatic SOD activity in the CCl4 group sh owed significantly lower than that in the control group. The activity of SOD in other three CCl 4 groups was not significantly different compared with that in the control group. Hepatic catal ase activity in the CCl4+5 HEC group showed significantly higher than that in the CCl4 grou  p. The total antioxidant status in the CCl4 group significantly lower than that in other groups.

Additionally, hepatic MDA concentration in the CCl4 group was significantly higher than that

in the control group. However, MDA concentration in both CCl4+1 HEC and CCl4+5 HEC  

groups’ was not significantly different compared with that in the control group. The pathologi

c results showed that liver fibrosis was ameliorated in the CCl4+1 HEC and CCl4+5 HEC gr  

oups compared with that in the CCl4 group. In addition, both CCl4+1 HEC and 5 HEC grou  

ps significantly decreased plasma total cholesterol compared with the CCl4 group. These resul

ts suggest that HEC can improve hepatic antioxidative capacity and decrease liver fibrosis occ

urring in rats with CCl4-induced liver damage.

參考文獻

相關文件

這是我最喜歡的版本,因為空間有限,一下子擠著四十

Rapiacta 因不經肝代謝,故透過 CYP 機轉與其他藥物發生 交互作用之可能性應該很低,就目前所知的排除途徑以及從 體外試驗可推知 Rapiacta 並不會誘導或抑制 CYP 450。 1)

開發職場安全 防災與智慧監 控技術,掌握 職業衛生危害 問題與預防技 術,提升職場 危害因子暴露 評估與職業傷 病預防,落實

理論,則認為人的情緒不是單純由事件本身引發的,更多是由當事人對事件的 理解或看法而引起的。ABC 理論的 A 是指誘發事件 (Activating

學生收集聲效, 擬訂場景、 道具、 服裝等 進行拍攝, 完成後運用Ul ead Vi deo St udi o 進行剪輯, 加入劇目標題、 特別效果及製作 人員名單,

• 對十八歲以下人士作出危 害或損害其身/心健康發 展的行為,或不作出某行 為以致兒童的身/心健康 發展受危害或損害。..

• 該行為對兒童的身心健康發展已 造成的傷害及可 能造成的影響,而不是作出/不作出某行為的人 是否有 傷害兒童的意圖.. •

本研究將針對 TFT-LCD 產業研發單位主管與研發人員進行 探討,並就主管於研發人員對職能重視程度作差異性分析。因此